Crescent Biopharma, Inc. Common Stock (CBIO)

Typically moves ±6.17% on earnings
EARNINGS ANALYTICS
event_note Approx. Next Earnings: ~2026-11-20 APPROXIMATE
search

Across 19 earnings reports since Aug 05, 2021, Crescent Biopharma, Inc. Common Stock (CBIO) has a clear post-earnings pattern. It moves ±6.17% on average after reporting and finishes higher 57.9% of the time. Its largest post-earnings gain was +22.02% (Nov 09, 2022) and its largest decline was -12.99% (Mar 03, 2022). The next earnings report is predicted for 2026-11-20 (approximate).

Earnings reactions

How CBIO moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

19

Avg Abs. Movement

±6.17%

Positive %

57.9%

Negative %

42.1%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Jul 30, 2026 ☀ PRE +2.39% open_in_new
Jul 14, 2026 ☽ POST +2.41% open_in_new
Apr 29, 2026 ☽ POST +7.34% open_in_new
Feb 26, 2026 ☀ PRE -1.4% open_in_new
event

Earnings Count

19

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.17%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 17 →
17
Funds holding
$43662828
Total value held
Buying
13 added · 4 reduced
Blackrock, Inc.
$22891716 +998.95%
State Street Corp
$5680566 +707.81%
Ameriprise Financial Inc
$5446224 NEW BUY
Ubs Group Ag
$3153276 NEW BUY
Northern Trust Corp
$2498004 +705.49%

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
EFFECT 20260731 open_in_new SEC.gov
10-Q 20260730 open_in_new SEC.gov
424B3 20260730 open_in_new SEC.gov
8-K 20260730 open_in_new SEC.gov
POS AM 20260730 open_in_new SEC.gov
4 20260720 open_in_new SEC.gov
SCHEDULE 13D/A 20260720 open_in_new SEC.gov
424B5 20260715 open_in_new SEC.gov
8-K 20260715 open_in_new SEC.gov

Frequently asked about CBIO earnings

When does Crescent Biopharma, Inc. Common Stock report earnings next? expand_more

Crescent Biopharma, Inc. Common Stock (CBIO)'s next earnings date is approximate for 2026-11-20. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does CBIO stock move after earnings? expand_more

Over 19 reports, CBIO has moved an average of ±6.17% the session after earnings, closing higher 57.9% of the time.

What was CBIO's biggest post-earnings move? expand_more

CBIO's largest post-earnings gain on record was +22.02% on Nov 09, 2022, and its largest decline was -12.99% on Mar 03, 2022.

Where can I find Crescent Biopharma, Inc. Common Stock's SEC filings? expand_more

All of Crescent Biopharma, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers